{"id":"W2744041560","doi":"10.1038/leu.2017.247","title":"Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network; University of Toronto; McMaster University","funders":"Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Imatinib; Medicine; Randomized controlled trial; Oncology; Internal medicine; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002626761,0.001261869,0.002767426,0.0002553424,0.0003035259,0.001335643,0.0007719016,0.001318902,0.005779674],"category_scores_gemma":[0.002130357,0.0004860865,0.003611477,0.0002742828,0.001011808,0.001800359,0.0008188951,0.004151335,0.0008144939],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009818339,"about_ca_system_score_gemma":0.0008386644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004959551,"about_ca_topic_score_gemma":0.002866927,"domain_scores_codex":[0.9985911,0.0008112585,0.00008283498,0.0002107632,0.00007782613,0.0002261799],"domain_scores_gemma":[0.9986734,0.0003750291,0.0003322811,0.0001286261,0.00007079033,0.0004198277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9337139,0.002614468,0.002356165,0.00102448,0.004537094,0.00009303734,0.0000777356,0.001118373,0.004556759,0.0004975735,0.004789056,0.04462132],"study_design_scores_gemma":[0.9179646,0.06444576,0.006842089,0.0001203793,0.002842074,0.0001775765,0.0000522195,0.0006312152,0.0009578417,0.001066805,0.004850496,0.0000489118],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9665658,0.01439648,0.001682142,0.003663219,0.0009262369,0.001898185,0.003615838,0.0002591854,0.006992977],"genre_scores_gemma":[0.9801589,0.003125864,0.002210979,0.004067311,0.0005297667,0.001693683,0.003634803,0.00007127115,0.00450734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005779674,"threshold_uncertainty_score":0.01933497,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0239290547485834,"score_gpt":0.2993948302622677,"score_spread":0.2754657755136843,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}